| __timestamp | Bausch Health Companies Inc. | ImmunityBio, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 246000000 | 1595000 |
| Thursday, January 1, 2015 | 582800000 | 11434000 |
| Friday, January 1, 2016 | 455000000 | 26546000 |
| Sunday, January 1, 2017 | 366000000 | 39778000 |
| Monday, January 1, 2018 | 414000000 | 53418000 |
| Tuesday, January 1, 2019 | 471000000 | 111997000 |
| Wednesday, January 1, 2020 | 452000000 | 139507000 |
| Friday, January 1, 2021 | 465000000 | 195958000 |
| Saturday, January 1, 2022 | 529000000 | 248149000 |
| Sunday, January 1, 2023 | 604000000 | 232366000 |
Unleashing insights
In the ever-evolving landscape of pharmaceuticals, research and development (R&D) investments are pivotal for innovation and growth. Over the past decade, Bausch Health Companies Inc. and ImmunityBio, Inc. have demonstrated contrasting strategies in their R&D expenditures. Bausch Health has consistently increased its R&D spending, peaking in 2023 with a 145% rise from 2014. This commitment underscores their focus on expanding their product pipeline and enhancing existing treatments. In contrast, ImmunityBio, Inc. has shown a remarkable growth trajectory, with R&D expenses surging by over 14,500% from 2014 to 2023. This dramatic increase highlights their aggressive pursuit of groundbreaking therapies, particularly in immunotherapy. As these companies continue to invest in R&D, they not only drive their own growth but also contribute significantly to advancements in healthcare, promising a future of innovative treatments and improved patient outcomes.
Research and Development Investment: Eli Lilly and Company vs Bausch Health Companies Inc.
Research and Development Investment: Sanofi vs Bausch Health Companies Inc.
Research and Development: Comparing Key Metrics for argenx SE and Bausch Health Companies Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and ImmunityBio, Inc.
Who Prioritizes Innovation? R&D Spending Compared for United Therapeutics Corporation and Bausch Health Companies Inc.
Analyzing R&D Budgets: Sarepta Therapeutics, Inc. vs ImmunityBio, Inc.
R&D Insights: How Corcept Therapeutics Incorporated and ImmunityBio, Inc. Allocate Funds
Analyzing R&D Budgets: Veracyte, Inc. vs Bausch Health Companies Inc.
R&D Insights: How ACADIA Pharmaceuticals Inc. and Bausch Health Companies Inc. Allocate Funds
Research and Development Expenses Breakdown: Bausch Health Companies Inc. vs Mesoblast Limited
Analyzing R&D Budgets: Bausch Health Companies Inc. vs Ligand Pharmaceuticals Incorporated
Who Prioritizes Innovation? R&D Spending Compared for ImmunityBio, Inc. and Mesoblast Limited